Executive Vice President, Chief Human Resources Officer · AbbVie Inc. (ABBV)

Timothy Richmond

FY2024 is the first fiscal year CompBrief holds for Timothy Richmond as a named executive officer of AbbVie; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$10,303,536

Salary $1,021,923Stock awards $3,832,822

5th of 6 named executive officers at AbbVie by FY2024 total.

6 named officers on file for AbbVie, FY2024

Timothy Richmond’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 3 equity grants, each cited to its filing
  • ABBV’s disclosed peer group of 9 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how AbbVie’s whole pay program stands against its peers

  • AbbVie’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABBV→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 24, 2025 (DEF 14A).

Free

Get Timothy Richmond’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Timothy Richmond compensation by year

AbbVie Summary Compensation Table · the one fiscal year held
In US dollars, as AbbVie reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$1,021,923
Bonus$0
Stock awards$3,832,822
Option awards$914,307
Non-equity incentive$1,950,000
Pension and deferred compensation$1,711,768
All other$872,716
Total$10,303,536

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AbbVie Inc. DEF 14A filed March 24, 2025, accession 0001558370-25-003537, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AbbVie Inc. filed document, accession 0001558370-25-003537. Every figure is read from that document and cited to the page and table it appears in. Filed March 24, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
PSU28,595$5,081,332—
PSU20,994$3,730,634—
PSU14,480$2,573,096—
Option11,675—$144.54
Option14,629—$149.62
Option28,998—$175.28

Per the Outstanding Equity Awards at Fiscal Year-End table in AbbVie Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

AbbVie’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Richard GonzalezExecutive Chairman of the Board$28,502,888
Robert MichaelChief Executive Officer$18,492,517
Jeffrey StewartExecutive Vice President, Chief Commercial Officer$14,047,300
Scott ReentsExecutive Vice President, Chief Financial Officer$10,992,354
Timothy Richmond · this pageExecutive Vice President, Chief Human Resources Officer$10,303,536
Azita Saleki-GerhardtExecutive Vice President, Chief Operations Officer$9,916,481

The full AbbVie compensation record

free company brief

This page is one person within AbbVie's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the AbbVie proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AbbVie's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Timothy Richmond's compensation dossier · One-time report. No refunds.